#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5159907	F	Antibiofilm activity against Salmonella typhimurium ATCC 14028 assessed as inhibition of biofilm formation incubated for 24 hrs by crystal violet staining based spectrophotometry	Salmonella enterica subsp. enterica serovar Typhimurium	56		organism-based format	Scientific Literature
2.	ALA5159908	F	Antibiofilm activity against Salmonella typhimurium ATCC 14028 assessed as biofilm dispersal effect incubated for 24 hrs by crystal violet staining based spectrophotometry	Salmonella enterica subsp. enterica serovar Typhimurium	56		organism-based format	Scientific Literature
3.	ALA5159909	F	Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as log reduction in bacterial burden in gallblader at 5 mg/kg/day, ip administered for 5 to 15 consecutive days of post infection and measured on day 15 in presence of 1 mg/kg/day ciprofloxacin	Salmonella enterica subsp. enterica serovar Typhimurium	4		organism-based format	Scientific Literature
4.	ALA5159911	F	Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as reduction in bacterial burden in liver at 5 mg/kg/day, ip administered from 5 to 15 consecutive days of post infection and measured on day 15 in presence of 1 mg/kg/day ciprofloxacin	Salmonella enterica subsp. enterica serovar Typhimurium	4		organism-based format	Scientific Literature
5.	ALA5159912	F	Antibacterial activity against Salmonella typhimurium ATCC 14028 infected in 129X1/SvJ NRAMP +/+ mouse gallstone model assessed as reduction in bacterial burden in spleen at 5 mg/kg/day, ip administered from 5 to 15 consecutive days of post infection mand measured on day 15 in presence of 1 mg/kg/day ciprofloxacin	Salmonella enterica subsp. enterica serovar Typhimurium	4		organism-based format	Scientific Literature